Clinical Trials Logo

Urologic Diseases clinical trials

View clinical trials related to Urologic Diseases.

Filter by:

NCT ID: NCT01235143 Completed - Children Clinical Trials

Emergence Agitation Between Sevoflurane and Desflurane in Pediatric

Start date: May 2010
Phase: N/A
Study type: Interventional

Sevoflurane is the volatile anesthetic agent of choice in pediatric surgery. Nevertheless, sevoflurane anesthesia had the high incidence of emergence delirium compared to halothane and isoflurane.Bortone L et al.reported isoflurane for maintenance decreased incidence of emergence agitation compared to sevoflurane in unpremedicated preschool children under elective subumbilical surgery (32% versus 52% respectively). Desflurane is the new volatile anesthetic agent which provides faster recovery compared to sevoflurane.Valley et al.reported no significant differences between sevoflurane or desflurane anesthesia in children in term of the serious airway complication such as laryngospasm or desaturation excepted the number of coughing episodes were more frequent in the desflurane compared to sevoflurane (36 versus 18).Mayer J et al. reported sevoflurane had severity of Pediatric Anesthesia Emergence Delirium (PAED) scale higher than desflurane in ear, nose, throat inpatient surgery in children (12(2-20) versus 6(0-15) respectively) with no reported of incidence of emergence agitation between those two. Therefore, the investigators would like to compare the incidence of emergence agitation, recovery profile and respiratory events between desflurane and sevoflurane anesthesia in pediatric ambulatory urologic surgery under general anesthesia and combined with regional anesthesia.

NCT ID: NCT01232010 Completed - Kidney Diseases Clinical Trials

Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients

SK3530_RI_I
Start date: November 2009
Phase: Phase 1
Study type: Interventional

This study is designed to investigate the effect of renal impairment on the safety and pharmacokinetics of SK3530 in subjects with renal impairment compared to healthy subjects.

NCT ID: NCT01231997 Completed - Kidney Diseases Clinical Trials

Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients

DA8159_RI_I
Start date: November 2009
Phase: Phase 1
Study type: Interventional

This study is designed to assess the effect of renal impairment on the pharmacokinetics, safety and tolerability of udenafil in subjects with renal impairment compared to healthy subjects.

NCT ID: NCT00610233 Completed - Movement Disorder Clinical Trials

Effect of Deep Brain Stimulation on Lower Urinary Tract Function

Start date: June 2005
Phase: N/A
Study type: Interventional

The precise mechanisms underlying cerebral regulation of lower urinary tract (LUT) function are still poorly understood. Patients with deep brain stimulation (DBS) offer the unique opportunity to investigate the role of different cerebral centers on LUT function. We hypothesize that DBS has a significant effect on LUT function and that these effects depend on the specific stimulated cerebral center.

NCT ID: NCT00610064 Completed - Clinical trials for Urinary Tract Disease

Brain Effects of Sacral Neuromodulation

Start date: October 2005
Phase: N/A
Study type: Interventional

Sacral neuromodulation (SNM) has become an accepted treatment for patients with refractory lower urinary tract dysfunction such as urgency frequency syndrome, urgency incontinence, non-obstructive chronic urinary retention and chronic pelvic pain syndrome. Modulation of central afferent activity is considered critical to this therapeutic effect but the neural mechanisms are poorly understood. We hypothesize that SNM has a significant effect on brain activity detectable by positron emission tomography (PET).

NCT ID: NCT00526331 Completed - Prostate Cancer Clinical Trials

Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether the early identification and more precise intervention of operating room (OR) patient fluid administration optimization using arterial pressure-based cardiac output (APCO) yields comparable patient outcome as fluid administration optimization using a global standard care method.

NCT ID: NCT00395564 Completed - Urologic Diseases Clinical Trials

Chart Review of Those Who Have Had Open, Laparoscopic, Ureteroscopic, or Percutaneous Surgery

Start date: November 2008
Phase: N/A
Study type: Observational

The investigator intends to review retrospective de-identified data of patients who have had Open, Laparoscopic, Ureteroscopic or Percutaneous Urologic Surgery.

NCT ID: NCT00258102 Completed - Clinical trials for Urinary Tract Infections

A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections

Start date: January 1993
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the safety and effectiveness of oral levofloxacin (an antibiotic) with that of oral lomefloxacin in the treatment of complicated urinary tract infections in adults.

NCT ID: NCT00258089 Completed - Clinical trials for Urinary Tract Infections

A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections

Start date: June 1993
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the safety and effectiveness of oral levofloxacin (an antibiotic) with that of oral ciprofloxacin in the treatment of complicated urinary tract infections in adults.

NCT ID: NCT00239317 Completed - Clinical trials for Urinary Tract Diseases

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Tamusulosin is effective in the treatment of lower urinary tract syndrome with male patients.